Rebecca Moore chosen as 2020 Hutchinson Harold M Weintraub Graduate Student
March 3, 2020

Rebecca Moore, a MOL Graduate Student in the Murphy lab, was chosen as a Harold M Weintraub Graduate Student by the Fred Hutchinson Cancer Research Center

Princeton, Rutgers and NJIT receive $29 million translational grant
Feb. 27, 2020

Princeton, Rutgers and NJIT have received a CTSA grant from the NIH to speed translation of research into innovations that can lead to improvements in patient and public health. Dan Notterman is the lead PI for Princeton.

Alexander Ploss awarded Accelerator Funding for Hep B research
Feb. 18, 2020

With funding from the IP Accelerator Fund, molecules that show activity against HBV will be further tested in cell culture and animal models developed by the Ploss group.

Yibin Kang's immunotherapy work supported by Accelerator Funding
Feb. 18, 2020

Kang lab researchers are exploring ways to extend the benefits of immunotherapy to more cancer types, including breast tumor cells. Princeton University's IP Accelarator Funding will help support this research.

Alexei Korennykh awarded funding from PU's Intellectual Property Accelerator Fund
Feb. 18, 2020

Alexei Korrenykh's research has been awarded funding from the University’s Intellectual Property Accelerator Fund, which aims to speed the development of innovative projects into real-world applications.

Martin Wühr develops mathematical model of cellular enzyme behavior
Feb. 13, 2020

Princeton researchers, including Martin Wühr, have devised a new mathematical technique to describe the behavior of many cellular enzymes. The approach will help researchers determine how genetic mutations change the behavior of these enzymes to cause a range of human diseases, including cancer.

Mohammed Donia publishes study on the human microbiome
Feb. 7, 2020

The microbial community populating the human body plays an important role in health and disease, but with few exceptions, how individual microbial species affect health and disease states remains poorly understood. A new study by Princeton researcher Mohamed Abou Donia and his colleagues, appearing in the Dec. 13 issue of the journal Science, gives scientists new tools to explore and understand the human microbiome.

Burdine and Shvartsman release study: Optical switch illuminates cells' development
Feb. 7, 2020

Combining light and a protein linked to cancer, researchers at Princeton University have created a biological switch to conduct an unprecedented exploration of cellular development in the embryo.

Martin Jonikas receives Vilcek Prizes honoring immigrants’ outstanding contributions
Feb. 7, 2020

Martin Jonikas, assistant professor of molecular biologyhas received a 2020 Vilcek Foundation Prize, which recognize the career achievements and creative promise of foreign-born innovators in the sciences, arts and humanities.

Bonnie Bassler receives Gruber Genetics Prize
Feb. 7, 2020

Bonnie Bassler will receive the 2020 Gruber Genetics Prize for her pioneering work on how bacteria communicate with each other.   

Bonnie Bassler Awarded GSA Medal
Jan. 30, 2020

Bonnie Bassler has been awarded the Genetics Society of America medal in recognition of her groundbreaking studies of bacterial chemical communication.

Esteban Engel: Novel gene-delivery technology for treatment of disease
Jan. 16, 2020

A newly developed system for turning on the therapeutic activity of genes could benefit the treatment of a broad range of genetic diseases.

Petry Lab recreates branching microtubule nucleation in a test tube
Jan. 15, 2020

Researchers in the Petry Lab have successfully recreated a key process involved in cell division in a test tube, uncovering the vital role played by a protein that is elevated in over 25% of all cancers.

Students visit States of Health exhibit at University Art Museum
Jan. 13, 2020

Professor Dan Notterman and students in MOL 460 Diseases in Children visiting the States of Health: Visualizing Illness and Healing exhibit at the University Art Museum through February 2

Ploss Research Featured in Celebrate Princeton Innovation Video Series
Dec. 31, 2019

Building on his lab’s expertise in human liver pathogens, Alexander Ploss and his team have pioneered new screening platforms and new methods to evaluate therapeutic candidates.